Form4insider filings, from the source

Company · CIK 0001369290 · SIC 3842 — Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE

MYOMO, INC. · MYO

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $51k · 1sales $149k · 4net −$98k
$10k$10k$100k$100k$1M$1MbuyssalesSep 2024Jan 2025May 2025Sep 2025Jan 2026May 2026Sep 2026

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 11, 2026 SForm 4 →Sep 14, 4:30 pm EDTHarry KovelmanChief Medical Officer15,488$1.27$19,68490,245−14.6%
Sep 2, 2026 SForm 4 →Sep 4, 4:30 pm EDTMilton Mayo MorrisDirector15,000$1.41$21,150208,391−6.71%
Aug 20, 2026 SForm 4/A →Aug 24, 8:08 am EDTHarry KovelmanChief Medical Officer17,500$1.73$30,329105,733−14.2%
Aug 20, 2026 SForm 4 →Aug 21, 6:17 pm EDTHarry KovelmanChief Medical Officer17,250$1.73$29,896105,983−14.0% amended
Aug 7, 2026 AFForm 4 →Aug 11, 8:07 am EDTHarry KovelmanChief Medical Officer77,606$1.42$31,889123,233—
Aug 7, 2026 AFForm 4 →Aug 11, 8:00 am EDTMicah MitchellChief Commercial Officer79,968$1.42$30,614130,738—
Aug 7, 2026 AForm 4 →Aug 11, 7:54 am EDTPaul R GudonisChief Executive Officer, Director146,909——1,434,679—
Aug 7, 2026 AFForm 4 →Aug 11, 7:51 am EDTDavid A HenryChief Financial Officer93,954$1.42$35,940470,163—
Jul 10, 2026 AFForm 4 →Jul 13, 4:39 pm EDTDavid A HenryChief Financial Officer13,006$1.09$5,631426,829—
Jul 10, 2026 AForm 4 →Jul 13, 4:32 pm EDTPaul R GudonisChief Executive Officer, Director10,454——1,287,770—
Jun 25, 2026 AForm 4 →Jun 26, 6:04 pm EDTJoseph M. Manko Jr.Director78,704——78,704—
Jun 25, 2026 AForm 4 →Jun 26, 5:13 pm EDTThomas Aloysius Crowley Jr.Director78,704——154,452—
Jun 25, 2026 AForm 4 →Jun 26, 5:12 pm EDTThomas F KirkDirector78,704——772,569—
Jun 25, 2026 AForm 4 →Jun 26, 5:11 pm EDTHeather C GetzDirector78,704——210,458—
Jun 25, 2026 AForm 4 →Jun 26, 5:10 pm EDTWilliam J FebboDirector78,704——123,704—
Jun 25, 2026 AForm 4 →Jun 26, 5:09 pm EDTMilton Mayo MorrisDirector78,704——223,391—
Jun 12, 2026 FForm 4 →Jun 12, 5:06 pm EDTHarry KovelmanChief Medical Officer10,442$1.20$12,53090,541—
Jun 12, 2026 FForm 4 →Jun 12, 4:59 pm EDTMicah MitchellChief Commercial Officer9,061$1.20$10,87393,888—
Jun 12, 2026 FForm 4 →Jun 12, 4:48 pm EDTDavid A HenryChief Financial Officer10,969——424,155—
Jun 8, 2026 FForm 4 →Jun 9, 4:44 pm EDTMicah MitchellChief Commercial Officer6,529$1.33$8,684102,949—
Jun 8, 2026 FForm 4 →Jun 9, 4:38 pm EDTHarry KovelmanChief Medical Officer7,635$1.33$10,155100,983—
Jun 8, 2026 FForm 4 →Jun 9, 4:11 pm EDTDavid A HenryChief Financial Officer10,050——435,124—
Jun 5, 2026 PForm 4 →Jun 9, 4:07 pm EDTThomas F KirkDirector40,002$1.27$50,803693,865+6.12%
May 14, 2026 SForm 4/A →Jun 8, 4:27 pm EDTMicah MitchellChief Commercial Officer90,231$0.861$77,689109,478−45.2%

Reported at this company — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.